Dynamin 3 Inhibits the Proliferation of Non-small-Cell Lung Cancer Cells by Suppressing c-MET–GBR2–STAT3 Complex Formation

Dynamin 3 (DNM3) has gained increased attention ever since its potential as a tumor suppressor was reported. However, its action in lung cancer (LC) is undefined. In this study, the role of DNM3 in LC development was investigated. DNM3 expression was found to be downregulated in tumors of patients w...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiang Lu, Yunfeng Ni, Wuping Wang, Lei Wang, Tao Jiang, Lei Shang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.641403/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850136598118662144
author Qiang Lu
Yunfeng Ni
Wuping Wang
Lei Wang
Tao Jiang
Lei Shang
author_facet Qiang Lu
Yunfeng Ni
Wuping Wang
Lei Wang
Tao Jiang
Lei Shang
author_sort Qiang Lu
collection DOAJ
description Dynamin 3 (DNM3) has gained increased attention ever since its potential as a tumor suppressor was reported. However, its action in lung cancer (LC) is undefined. In this study, the role of DNM3 in LC development was investigated. DNM3 expression was found to be downregulated in tumors of patients with LC, especially those with metastasis. The DNM3 downregulation enhanced the proliferative and metastatic ability of LC cells, whereas its upregulation had the opposite effects. In vivo xenograft experiments confirmed that lung tumors with lower DNM3 expression had higher growth and metastatic abilities. Mechanistic studies revealed that DNM3 interacts with growth factor receptor-bound protein 2 (GBR2), thereby interrupting tyrosine-protein kinase Met (c-MET)–GBR2–signal transducer and activator of transcription 3 (STAT3) complex formation, which suppressed STAT3 activation. Therefore, the absence of DNM3 frees GBR2 to activate STAT3, which regulates the expression of genes related to LC proliferation and metastasis (e.g., cyclin D1 and Snail family transcriptional repressor 1). Additionally, the c-MET inhibitor crizotinib effectively suppressed LC cell proliferation and migration in vitro and in vivo, even with DNM3 depleted. Therefore, our study has demonstrated the antitumor effect of DNM3 in LC and suggests that the inhibition of c-MET might be a promising strategy for treating those LC patients with low DNM3 expression.
format Article
id doaj-art-ef1adb7455be4e0a991a8c2cf77e2f0f
institution OA Journals
issn 2296-634X
language English
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj-art-ef1adb7455be4e0a991a8c2cf77e2f0f2025-08-20T02:31:04ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2021-08-01910.3389/fcell.2021.641403641403Dynamin 3 Inhibits the Proliferation of Non-small-Cell Lung Cancer Cells by Suppressing c-MET–GBR2–STAT3 Complex FormationQiang Lu0Yunfeng Ni1Wuping Wang2Lei Wang3Tao Jiang4Lei Shang5Department of Thoracic Surgery, Tangdu Hospital, The Air Force Military Medical University, Xi’an, ChinaDepartment of Thoracic Surgery, Tangdu Hospital, The Air Force Military Medical University, Xi’an, ChinaDepartment of Thoracic Surgery, Tangdu Hospital, The Air Force Military Medical University, Xi’an, ChinaDepartment of Thoracic Surgery, Tangdu Hospital, The Air Force Military Medical University, Xi’an, ChinaDepartment of Thoracic Surgery, Tangdu Hospital, The Air Force Military Medical University, Xi’an, ChinaThe Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, Department of Health Statistics, School of Public Health, The Air Force Military Medical University, Xi’an, ChinaDynamin 3 (DNM3) has gained increased attention ever since its potential as a tumor suppressor was reported. However, its action in lung cancer (LC) is undefined. In this study, the role of DNM3 in LC development was investigated. DNM3 expression was found to be downregulated in tumors of patients with LC, especially those with metastasis. The DNM3 downregulation enhanced the proliferative and metastatic ability of LC cells, whereas its upregulation had the opposite effects. In vivo xenograft experiments confirmed that lung tumors with lower DNM3 expression had higher growth and metastatic abilities. Mechanistic studies revealed that DNM3 interacts with growth factor receptor-bound protein 2 (GBR2), thereby interrupting tyrosine-protein kinase Met (c-MET)–GBR2–signal transducer and activator of transcription 3 (STAT3) complex formation, which suppressed STAT3 activation. Therefore, the absence of DNM3 frees GBR2 to activate STAT3, which regulates the expression of genes related to LC proliferation and metastasis (e.g., cyclin D1 and Snail family transcriptional repressor 1). Additionally, the c-MET inhibitor crizotinib effectively suppressed LC cell proliferation and migration in vitro and in vivo, even with DNM3 depleted. Therefore, our study has demonstrated the antitumor effect of DNM3 in LC and suggests that the inhibition of c-MET might be a promising strategy for treating those LC patients with low DNM3 expression.https://www.frontiersin.org/articles/10.3389/fcell.2021.641403/fulldynamin 3lung cancernon-small-cell lung cancergrowth factor receptor-bound protein 2antitumor effect
spellingShingle Qiang Lu
Yunfeng Ni
Wuping Wang
Lei Wang
Tao Jiang
Lei Shang
Dynamin 3 Inhibits the Proliferation of Non-small-Cell Lung Cancer Cells by Suppressing c-MET–GBR2–STAT3 Complex Formation
Frontiers in Cell and Developmental Biology
dynamin 3
lung cancer
non-small-cell lung cancer
growth factor receptor-bound protein 2
antitumor effect
title Dynamin 3 Inhibits the Proliferation of Non-small-Cell Lung Cancer Cells by Suppressing c-MET–GBR2–STAT3 Complex Formation
title_full Dynamin 3 Inhibits the Proliferation of Non-small-Cell Lung Cancer Cells by Suppressing c-MET–GBR2–STAT3 Complex Formation
title_fullStr Dynamin 3 Inhibits the Proliferation of Non-small-Cell Lung Cancer Cells by Suppressing c-MET–GBR2–STAT3 Complex Formation
title_full_unstemmed Dynamin 3 Inhibits the Proliferation of Non-small-Cell Lung Cancer Cells by Suppressing c-MET–GBR2–STAT3 Complex Formation
title_short Dynamin 3 Inhibits the Proliferation of Non-small-Cell Lung Cancer Cells by Suppressing c-MET–GBR2–STAT3 Complex Formation
title_sort dynamin 3 inhibits the proliferation of non small cell lung cancer cells by suppressing c met gbr2 stat3 complex formation
topic dynamin 3
lung cancer
non-small-cell lung cancer
growth factor receptor-bound protein 2
antitumor effect
url https://www.frontiersin.org/articles/10.3389/fcell.2021.641403/full
work_keys_str_mv AT qianglu dynamin3inhibitstheproliferationofnonsmallcelllungcancercellsbysuppressingcmetgbr2stat3complexformation
AT yunfengni dynamin3inhibitstheproliferationofnonsmallcelllungcancercellsbysuppressingcmetgbr2stat3complexformation
AT wupingwang dynamin3inhibitstheproliferationofnonsmallcelllungcancercellsbysuppressingcmetgbr2stat3complexformation
AT leiwang dynamin3inhibitstheproliferationofnonsmallcelllungcancercellsbysuppressingcmetgbr2stat3complexformation
AT taojiang dynamin3inhibitstheproliferationofnonsmallcelllungcancercellsbysuppressingcmetgbr2stat3complexformation
AT leishang dynamin3inhibitstheproliferationofnonsmallcelllungcancercellsbysuppressingcmetgbr2stat3complexformation